Assessing a Clinically-meaningful Opioid Withdrawal Phenotype

Abroad (travel likely)RecruitingPHASE2

Conditions

Opioid Withdrawal · Opioid Use Disorder · Opioid Craving

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Maryland, Baltimore, Maryland, United States
Contact: Study coordinator (Kelly E Dunn, PhD, MBA) · kelly.dunn@som.umaryland.edu · 802-922-1682
Contact: Principal Investigator (Kelly E Dunn, PhD, MBA)

Study leads

Kelly E Dunn, Ph.D, M.B.A.
Principal Investigator
University of Maryland

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating Buspirone to Treat Opioid Withdrawal

Opioid Use Disorder · Opioid Withdrawal · Opioid Craving

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Opioid Withdrawal · Opioid Use Disorder

Abroad (travel likely)Recruiting

Center City, United States · Columbus, United States

Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder

Opioid Withdrawal · Opioid Use Disorder (OUD)

Abroad (travel likely)Recruiting

Pittsburgh, United States

CEDRN: Opioid Registry

Opioid Use Disorder · Opioid Abuse or Dependence · Opioid Withdrawal

Abroad (travel likely)Recruiting

Vancouver, Canada